NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $7.73 -0.06 (-0.77%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$7.62▼$8.1350-Day Range$5.86▼$7.7952-Week Range$5.45▼$14.37Volume330,548 shsAverage Volume595,574 shsMarket Capitalization$456.30 millionP/E RatioN/ADividend YieldN/APrice Target$11.91 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Health Catalyst alerts: Email Address Health Catalyst MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.73 Rating ScoreUpside/Downside54.1% Upside$11.91 Price TargetShort InterestBearish4.12% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.60Based on 5 Articles This WeekInsider TradingSelling Shares$54,889 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.40) to ($0.16) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.01 out of 5 starsMedical Sector192nd out of 936 stocksComputer Programming, Data Processing, & Other Computer Related Industry14th out of 60 stocks 3.4 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageHealth Catalyst has only been the subject of 4 research reports in the past 90 days.Read more about Health Catalyst's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.12% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Health Catalyst has recently increased by 17.39%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 2.6 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Health Catalyst this week, compared to 3 articles on an average week.MarketBeat Follows3 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $54,889.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.40) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Health Catalyst Stock (NASDAQ:HCAT)Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Read More HCAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesJuly 9, 2024 | insidertrades.comInsider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,208 Shares of StockJuly 26 at 2:04 AM | americanbankingnews.comAnalysts Set Health Catalyst, Inc. (NASDAQ:HCAT) PT at $11.91July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 19, 2024 | finance.yahoo.comShareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years agoJuly 18, 2024 | prnewswire.comHealth Catalyst Announces New Credit Facility for up to $225,000,000July 18, 2024 | americanbankingnews.comShort Interest in Health Catalyst, Inc. (NASDAQ:HCAT) Expands By 9.5%July 16, 2024 | investorplace.com3 Overlooked Telehealth Stocks Poised for a ComebackJune 6, 2024 | prnewswire.comHealth Catalyst Acquires Oncology-Focused Health Technology Company CareviveJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 30, 2024 | globenewswire.comHealth Catalyst to Participate in Upcoming Investor ConferencesMay 29, 2024 | finance.yahoo.comZacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health CatalystMay 21, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring Health Catalyst Through Analyst InsightsMay 21, 2024 | prnewswire.comHealth Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®May 13, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Hold Rating on Health Catalyst (HCAT)May 11, 2024 | finance.yahoo.comHealth Catalyst First Quarter 2024 Earnings: EPS Misses ExpectationsMay 10, 2024 | finanznachrichten.deHealth Catalyst, Inc.: Health Catalyst Reports First Quarter 2024 ResultsMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Health Catalyst Amidst Solid Financials and Strong Prospects for New Ignite PlatformMay 10, 2024 | finance.yahoo.comHealth Catalyst Inc (HCAT) Q1 2024 Earnings: Modest Revenue Growth and Strategic Financial ...See More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Confirmed)8/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryComputer Software Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$11.91 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+52.3%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-118,150,000.00 Net Margins-35.56% Pretax Margin-35.43% Return on Equity-11.86% Return on Assets-6.26% Debt Debt-to-Equity RatioN/A Current Ratio4.31 Quick Ratio4.31 Sales & Book Value Annual Sales$295.94 million Price / Sales1.56 Cash FlowN/A Price / Cash FlowN/A Book Value$6.38 per share Price / Book1.23Miscellaneous Outstanding Shares59,030,000Free Float57,441,000Market Cap$461.61 million OptionableOptionable Beta1.32 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Daniel H. Orenstein (Age 54)Senior Advisor Comp: $356.56kMr. Kevin Freeman (Age 51)Chief Commercial Officer Comp: $405.9kMr. Jason Alger (Age 40)CFO & Chief Accounting Officer Mr. Daniel LeSueurChief Operating OfficerMr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate DevelopmentMore ExecutivesKey CompetitorsVNET GroupNASDAQ:VNETAurora MobileNASDAQ:JGEverQuoteNASDAQ:EVERHealthStreamNASDAQ:HSTMModel NNYSE:MODNView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 259,263 shares on 7/26/2024Ownership: 3.777%Baillie Gifford & Co.Sold 106,171 shares on 7/25/2024Ownership: 0.729%Perfromance Wealth Partners LLCBought 10,000 shares on 7/22/2024Ownership: 0.017%Nisa Investment Advisors LLCBought 5,232 shares on 7/20/2024Ownership: 0.011%Nepsis Inc.Bought 95,686 shares on 7/16/2024Ownership: 2.123%View All Insider TransactionsView All Institutional Transactions HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $9.26 on January 1st, 2024. Since then, HCAT stock has decreased by 16.5% and is now trading at $7.73. View the best growth stocks for 2024 here. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.14) EPS for the quarter, topping analysts' consensus estimates of ($0.19) by $0.05. The business earned $74.72 million during the quarter, compared to the consensus estimate of $74.81 million. Health Catalyst had a negative net margin of 35.56% and a negative trailing twelve-month return on equity of 11.86%. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's top institutional shareholders include Bank of New York Mellon Corp (3.78%), Nepsis Inc. (2.12%), Baillie Gifford & Co. (0.73%) and SG Americas Securities LLC (0.05%). Insiders that own company stock include Daniel D Burton, Bryan Truman Hunt, Paul Horstmeier, Daniel Lesueur, James Patrick Jr Nelli, Linda Llewelyn, Daniel H Orenstein, Jason Alger, Duncan Gallagher, Benjamin Landry and Bryan Richard Hinton. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ) and Slack Technologies (WORK). This page (NASDAQ:HCAT) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.